
From 'Symptomatic Treatment' to 'Precision Treatment of the Person': Fudan University Shanghai Cancer Center Proposes Precision System for Urological Tumors
Ye Dingwei's team pioneered the world's first urine RNA+AI non-invasive auxiliary diagnosis system for precise urothelial carcinoma screening (sensitivity 91.37%, specificity 95.09%). It advances organ-preserving treatment and domestic devices, with patient survival rates comparable to top international centers.
Fudan University Shanghai Cancer Center